Podcasts

Happy Birthday, CATIE!

Author and Disclosure Information

Editor-in-Chief Henry A. Nasrallah, MD, discusses how fundamentally understanding of the effectiveness of antipsychotics has changed in the 10 years since the CATIE study was published.


 

Recommended Reading

Non-drug therapies for refractory schizophrenia
MDedge Psychiatry
Medicaid scripts reveal rise in risky polypharmacy in children
MDedge Psychiatry
Burden of psychiatric comorbidity higher in MS patients
MDedge Psychiatry
Researchers highlight gaps in diabetes screening in patients on antipsychotics
MDedge Psychiatry
Protein synthesis slower in stem cells of schizophrenia patients
MDedge Psychiatry
A decade after the CATIE study, the focus has shifted from effectiveness to neuroprotection
MDedge Psychiatry
Cognitive impairment no different in treatment-resistant schizophrenia
MDedge Psychiatry
Schizophrenia patients, decision makers aligned on treatments
MDedge Psychiatry
Cerebellar soft signs similar in schizophrenia, bipolar
MDedge Psychiatry
Schizophrenia risk, loss of white matter integrity share genes, twin study shows
MDedge Psychiatry